Dr. Dishowitz manages a portfolio of PCI Ventures startup companies, focusing on the medical device, biotechnology, and therapeutic sectors. His primary responsibility is to build businesses that commercialize Penn intellectual property by recruiting management, developing business strategies, fundraising, supporting company operations, and executing deals. He is also the director of Penn’s medical device startup accelerator, DevelUPmed, and manages several capital acquisition and business development programs.
Prior to joining PCI Ventures, Mike was a member of ICON Commercialisation & Outcomes (formerly PriceSpective), a boutique consulting agency, where he specialized in asset valuation and pricing & market access of emerging life science technologies. Before entering industry, Mike spent several years in academia, studying the impact of cell signaling pathways on orthopaedic injury and repair. He is also co-founder of a startup company based on his thesis research that uses a combination drug-device to promote bone formation and regeneration.
Mike graduated with a B.S. in Mathematics from the University of Florida and a Ph.D. in Bioengineering from the University of Pennsylvania.